REV transdominant protein gene therapy (NIH)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameREV transdominant protein gene therapy (NIH)
Drug Alias NameRev -, Tat-, Nef-based vaccine (NIH)TAR gene therapy (NIH)GAG mutant gene therapy (NIH)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHIV replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A